New drug AIR-001 enters first human tests for rare lung condition
Disease control
Recruiting now
This early-stage trial tests a new drug called AIR-001 in 54 adults with alpha-1 antitrypsin deficiency (AATD) who have a specific genetic type (PiZZ). The study aims to check safety and how the body processes the drug. Participants receive increasing doses of AIR-001 under the s…
Phase: PHASE1 • Sponsor: AIRNA Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC